v3 Template
U

Until Labs

Healthcare/Biotechnology
Founded
--
Employees
--
Total Funding
$58.0M
Funding Rounds
1
Last Funding
2025-09-22

About Until Labs

Until is a company focused on advancing cryopreservation technology to save lives by ensuring donated organs are not lost to logistics and patients do not die waiting for transplants. Their mission is to extend organ viability from hours to weeks or months, ultimately aiming to eliminate waiting lists and enable whole-body reversible cryopreservation as a bridge to future cures.

Products & Services

Cryopreservation Technology for Organs:Extending the viability of whole human organs from hours to weeks or months to ensure no donated organ is lost and no patient dies waiting.
Whole-Body Reversible Cryopreservation:Developing technology to pause molecular motion, providing patients a bridge to future cures.

Specialties

Cryopreservation Organ Preservation Whole-Body Reversible Cryopreservation

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A
A: 58000000
MR: -
FA: 58 million
FAN: 58000000
D: 2025-09-22
FD: 2025-09-22
3 investors
Series A Latest
2025-09-22
$58.0M
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Until Labs Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare/Biotechnology

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro